We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

97 hedge funds and large institutions have $171M invested in Antares Pharma, Inc. in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 47 increasing their positions, 18 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 4

174% more call options, than puts

Call options by funds: $1.01M | Put options by funds: $368K

161% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 18

11% more funds holding

Funds holding: 87 → 97 (+10)

10% less capital invested

Capital invested by funds: $190M → $171M (-$18.9M)

Holders
97
Holders Change
+10
Holders Change %
+11.49%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
47
Reduced
18
Closed
4
Calls
$1.01M
Puts
$368K
Net Calls
+$640K
Net Calls Change
+$2.16M

Top Buyers

Rank Fund Capital Flow
1
HCM
Harvey Capital Management
Florida
+$2.31M
2
BFA
BlackRock Fund Advisors
California
+$1.67M
3
BIT
BlackRock Institutional Trust
California
+$1.01M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$964K
5
WHI
William Harris Investors
Illinois
+$546K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$21.1M
2
DM
Deerfield Management
New York
-$3.26M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$944K
4
UOC
UBS O'Connor
Illinois
-$913K
5
TCIM
TIAA CREF Investment Management
New York
-$666K
Name Holding Trade Value Shares
Change 		Change in
Stake
MWR
26
McAdams Wright Ragen
Washington
$992K +$45.6K +10,438 +4%
B
27
Baird
Wisconsin
$953K +$221K +50,700 +28%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$824K +$28.4K +6,498 +3%
ACM
29
Ashford Capital Management
Delaware
$729K -$206K -47,100 -21%
Deutsche Bank
30
Deutsche Bank
Germany
$677K +$306K +70,009 +72%
TA
31
Teachers Advisors
New York
$623K +$24.4K +5,585 +4%
NPC
32
National Planning Corporation
California
$614K +$84.7K +19,400 +16%
Wells Fargo
33
Wells Fargo
California
$542K +$8.73K +2,000 +2%
SIC
34
Salem Investment Counselors
North Carolina
$532K – – –
CS
35
Credit Suisse
Switzerland
$522K +$433K +99,107 +337%
Group One Trading
36
Group One Trading
Illinois
$455K +$21.4K +4,890 +5%
Swiss National Bank
37
Swiss National Bank
Switzerland
$443K -$44.5K -10,200 -9%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$438K +$25.8K +5,903 +6%
Citigroup
39
Citigroup
New York
$402K +$6.18K +1,414 +1%
AQR Capital Management
40
AQR Capital Management
Connecticut
$380K – – –
VOYA Investment Management
41
VOYA Investment Management
Georgia
$380K – – –
Morgan Stanley
42
Morgan Stanley
New York
$375K +$166K +37,997 +70%
MLICM
43
Metropolitan Life Insurance Company (MetLife)
New York
$364K -$9.59K -2,195 -2%
NFA
44
Nationwide Fund Advisors
Ohio
$364K +$30.3K +6,948 +8%
Goldman Sachs
45
Goldman Sachs
New York
$344K +$67.9K +15,550 +22%
IAM
46
Iridian Asset Management
Connecticut
$316K +$143K +32,780 +73%
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
$315K +$154K +35,300 +84%
AIG
48
American International Group
New York
$307K +$8.29K +1,899 +3%
SCM
49
Stevens Capital Management
Pennsylvania
$304K +$327K +74,934 New
VKH
50
Virtu KCG Holdings
New York
$302K +$324K +74,250 New
1
2
3 4

ATRS Hedge Fund Activity: Q3 2013 in Review

97 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q3 2013, worth a combined $171M — down 9.9% from $190M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ATRS positions and 4 closed out — a net gain of 10 holders — while 47 added to existing stakes and 18 trimmed.

The largest buyer was Harvey Capital Management, opening a new position worth an estimated $2.31M. The largest seller was OrbiMed, cutting an estimated $21.1M.

  • 97 institutional investors held Antares Pharma, Inc. (ATRS) as of Q3 2013, up from 87 in Q2 2013.
  • Funds reported $171M of Antares Pharma, Inc. stock for Q3 2013, down 9.9% quarter-over-quarter.
  • 14 funds opened new Antares Pharma, Inc. positions in Q3 2013 and 4 closed out, a net change of +10 holders.
  • The largest Antares Pharma, Inc. buyer in Q3 2013 was Harvey Capital Management, an estimated $2.31M added.
  • The largest Antares Pharma, Inc. seller in Q3 2013 was OrbiMed, an estimated $21.1M sold.

Based on aggregated 13F filings for Q3 2013.